Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs Wipro Limited (WIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs Wipro Limited — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.2 (market cap $7.04B), while Wipro Limited trades at $1.76 (market cap $17.75B). The key difference: Wipro Limited is far larger — about 2.5× Ionis Pharmaceuticals Inc. Common Stock's market cap, and Wipro Limited pays a 4.82% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and Wipro Limited for 41 Days on average.
| IONS | WIT | |
|---|---|---|
Market Cap | $7.04B | $17.75B |
Volume | 2,977,440 | 5,443,754 |
Sector | Health | Technology |
52-Week High | $86.50 | $3.06 |
52-Week Low | $42.38 | $1.61 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $6.60B | $15.84B |
Dividend Yield | — | 4.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
WIT trades at $1.80, up 5.88% today, with a bullish technical signal from moving averages. The company maintains solid fundamentals with $890.88B revenue and 13.92% net margin in 2025, though recent quarters show earnings misses. Positive developments include AI-driven productivity gains and new cybersecurity partnerships, while analyst sentiment remains mixed with 19% buy ratings.
WIT presents a cautious opportunity with reasonable valuation (P/E 13.84) and strong cash flow generation, but faces headwinds from earnings volatility and competitive IT services market. The stock's appeal hinges on execution of AI initiatives and margin improvement amid client spending constraints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About Wipro Limited
Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →
